Livingstone Health (SGX:PRH) will invest in a 30% stake in MetEndo or the Metabolic Clinic, according to a filing with the Singapore Exchange on Monday.
MetEndo is an endocrine specialist clinic, which provides comprehensive and holistic expert consultations to patients.
Through the partnership, Livingstone is targeting cross-collaboration between its healthcare professionals and network of practitioners.
The company's medical director, Dinesh Carl Junis Mahendran, owns a 70% stake in The Metabolic Clinic which will start its operations in June this year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.